Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Chemical probes are small, drug-like molecules that are useful in interrogating biology in disease models. In order for a...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved expanding the use of the...
Guest Post by Jenine Sanzari, PhD Stand Up To Cancer recently held its seventh annual Scientific Summit, organized by...
Saturday, February 4, is World Cancer Day, an initiative of the Union for International Cancer Control (UICC).
Cancer Today and the AACR are hosting a webinar on Feb. 16 at 1 p.m. EST. A panel of...
Patients have long benefited from combination treatments—whether combining surgery with chemotherapy and radiation, or combining chemotherapy agents in succession.
The FDA has approved expanding the use of the molecularly targeted therapeutic ibrutinib (Imbruvica) to include the treatment of...
A hot topic in the field of cancer immunotherapy is: How do some cancers that initially respond to immune...
The next step in trying to increase the proportion of patients who respond to these therapies, therefore, is to...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today Over the past few years, scientists have come...